Advances in end-to-end multiomics platforms and the underlying scientific knowledge now enable faster and more precise biomarker discovery, mechanistic insight generation, and therapeutic design—core drivers of modern drug discovery programs. The post Multiomics Mass Spec Workflows in Drug Discovery appeared first on GEN - Genetic Engineering and Biotechnology News .